Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:HLA-DR–expressing fibroblast-like synoviocytes are inducible antigen presenting cells that present autoantigens in Lyme arthritis
Authors:ID Rouse, Joseph R. (Author)
ID Danner, Rebecca (Author)
ID Wahhab, Amanda (Author)
ID Pereckas, Michaela (Author)
ID Nguyen, Christine (Author)
ID McClune, Mecaila E. (Author)
ID Steere, Allen C. (Author)
ID Strle, Klemen (Author)
ID Jutras, Brandon L. (Author)
ID Lochhead, Robert B. (Author), et al.
Files:.pdf PDF - Presentation file, download (2,14 MB)
MD5: EEE48FBBB463530321950D5E44A26A90
 
URL URL - Source URL, visit https://acrjournals.onlinelibrary.wiley.com/doi/full/10.1002/acr2.11710
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Objective: HLA-DR–expressing fibroblast-like synoviocytes (FLS) are a prominent cell type in synovial tissue in chronic inflammatory forms of arthritis. FLS-derived extracellular matrix (ECM) proteins, including fibronectin-1 (FN1), contain immunogenic CD4+ T cell epitopes in patients with postinfectious Lyme arthritis (LA). However, the role of FLS in presentation of these T cell epitopes remains uncertain. Methods: Primary LA FLS and primary murine FLS stimulated with interferon gamma (IFNγ), Borrelia burgdorferi, and/or B burgdorferi peptidoglycan (PG) were assessed for properties associated with antigen presentation. HLA-DR–presented peptides from stimulated LA FLS were identified by immunopeptidomics analysis. OT-II T cells were co-cultured with stimulated murine FLS in the presence of cognate ovalbumin antigen to determine the potential of FLS to act as inducible antigen presenting cells (APCs). Results: FLS expressed HLA-DR molecules within inflamed synovial tissue and tendons from patients with postinfectious LA in situ. Major histocompatibility complex (MHC) class II and co-stimulatory molecules were expressed by FLS following in vitro stimulation with IFNγ and B burgdorferi and presented both foreign and self-MHC-II peptides, including an immunogenic T cell epitope derived from Lyme autoantigen FN1. Stimulated FLS induced proliferation of naive OT-II CD4+ T cells that were dependent on OT-II antigen and CD40. Stimulation with B burgdorferi PG enhanced FLS-mediated T cell activation. Conclusion: MHC-II+ FLS are inducible APCs that can induce CD4+ T cell activation in an antigen- and CD40-dependent manner. Activated FLS can also present ECM-derived Lyme autoantigens, implicating FLS in amplifying tissue-localized autoimmunity in LA.
Keywords:Lyme arthritis, autoimmune diseases, infectious disease
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 678-689
Numbering:Vol. 6, issue 10
PID:20.500.12556/DiRROS-29643 New window
UDC:616.9
ISSN on article:2578-5745
DOI:10.1002/acr2.11710 New window
COBISS.SI-ID:279250691 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 25. 5. 2026;
Publication date in DiRROS:02.06.2026
Views:91
Downloads:50
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:ACR open rheumatology
Shortened title:ACR open rheumatol.
Publisher:John Wiley & Sons Inc.
ISSN:2578-5745
COBISS.SI-ID:529833497 New window

Document is financed by a project

Funder:NIH - National Institutes of Health
Project number:1R21AI148982-01
Name:MHC class II presentation of Borrelia burgdorferi and synovial tissue antigens in murine Lyme arthritis

Funder:NIH - National Institutes of Health
Project number:1R01AI173256-01
Name:Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease

Funder:NIH - National Institutes of Health
Project number:1R01AI178711-01
Name:The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Back